NCT01288170View on ClinicalTrials.gov

Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus®

NAUnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

July 31, 2010

Conditions
Cystic Fibrosis
Interventions
DRUG

Nebcinal Tobi

DRUG

Tobi Nebcinal

Trial Locations (2)

69495

NOT_YET_RECRUITING

Centre de ressources et de compétences pour la mucovisidose, adultes, Pierre-Bénite

69500

RECRUITING

Centre de ressources et de compétences pour la mucovisidose, enfants, Bron

Sponsors

Lead Sponsor

Erempharma
All Listed Sponsors
collaborator

Hospices Civils de Lyon

OTHER

collaborator

University of Lyon

OTHER

lead

Erempharma

INDUSTRY